Is Actinium Pharmaceuticals (ATNM) stock Halal?

Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer. The company's primary aim is to harness the power of radioisotopes in conjunction with proprietary tumor-targeting agents to improve outcomes for patients with difficult-to-treat cancers. Actinium's flagship platform, Antibody Radiation-Conjugates (ARCs), is designed to deliver potent radiation directly to cancer cells, minimizing exposure to healthy tissues and enhancing the potency of therapeutic regimens. For Muslim investors, though, the most pressing question is simpler: is Actinium Pharmaceuticals a Halal investment?

Is Actinium Pharmaceuticals Shariah compliant?

No. In the October 2026 screening Actinium Pharmaceuticals (ATNM) does not pass AAOIFI screening: it fails the interest-bearing investments screen. Technology companies rarely fail AAOIFI screening on what they sell. Software, hardware and digital services are permissible business activities, so for a company like Actinium Pharmaceuticals the Shariah question moves to the balance sheet: how much of its market value sits in interest bearing debt, how much of its cash earns Riba in conventional deposits, and whether incidental income from impermissible sources creeps past 5% of revenue. These are exactly the ratios AAOIFI Shariah Standard No. 21 polices, and they move every month with the share price.

Does Actinium Pharmaceuticals pass the business activity test?

The activity screen is only part of the picture this month: Actinium Pharmaceuticals currently fails the interest-bearing investments screen, so the overall verdict is not compliant regardless of the business itself. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.

Is Actinium Pharmaceuticals' income Halal?

Yes, within AAOIFI's tolerance. Actinium Pharmaceuticals' income from non-permissible sources stays below 5% of revenue in the October 2026 screening.

Does Actinium Pharmaceuticals meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing investments currently exceed the 30% cap, measured against a market capitalisation of $35.2M (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for Actinium Pharmaceuticals?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read Why a Halal Stock Screener Matters for Halal Investing